Table 1 Comparison of the patients with pancreatic cancer who had positive immunostaining for metastin and those negative.
From: Prognostic value of metastin expression in human pancreatic cancer
Characteristics | Positive for metastin | Negative for metastin | P value |
|---|---|---|---|
| Â | (n = 13) | (n = 40) | Â |
Age | 68.8 ± 7.2 (71, 56–78) | 64.5 ± 10.5 (65.5, 32–86) | 0.19 |
Gender | Â | Â | Â |
   Male | 6 | 19 | 0.93 |
   Female | 7 | 21 |  |
Location of tumor | Â | Â | Â |
   Pancreas head | 8 | 30 | 0.35 |
   Pancreas body-tail | 5 | 10 |  |
Size of tumor, cm | 2.5 ± 0.9 (2.5, 1.2–4.5) | 3.0 ± 1.2 (2.8, 0.8–6.5) | 0.34 |
Histopathological grading | Â | Â | Â |
   G1 | 5 | 9 | 0.26 |
   G2-4 | 8 | 31 |  |
pT | Â | Â | Â |
   pT1, pT2 | 2 | 6 | 0.97 |
   pT3 | 11 | 34 |  |
pN | Â | Â | Â |
   pN0 | 6 | 15 | 0.58 |
   pN1 | 7 | 25 |  |
Lymphatic invasion | Â | Â | Â |
   Positive | 7 | 24 | 0.70 |
   Negative | 6 | 16 |  |
Venous invasion | Â | Â | Â |
   Positive | 7 | 23 | 0.82 |
   Negative | 6 | 17 |  |
Perineural invasion | Â | Â | Â |
   Positive | 6 | 22 | 0.58 |
   Negative | 7 | 18 |  |
pStage | Â | Â | Â |
   I, II | 13 | 36 | 0.24 |
   IV | 0 | 4 |  |
Residual tumor | Â | Â | Â |
   R0 | 11 | 28 | 0.30 |
   R1 | 2 | 12 |  |